Table 1

Significant associations of HMG-CoA reductase expression with clinicopathological characteristics and investigative factors
HMG-CoA reductase expression
Factor Negative Positive P-value
N(%) 61 (11.4) 474 (88.6)
M stage
0 41(68.3) 395 (84.4) 0.002
1 19 (31.7) 73 (15.6)
Missing 1 6
Vascular invasion
No 11 (32.4) 142 (50.7) 0.043
Yes 23 (67.6) 138 (49.3)
Missing 17 194
Microsatellite instability
MSS 52(94.5) 371 (83.6) 0.033
MSI 3 (5.5) 73 (16.4)
Missing 6 30
Cyclin D1 expression
Negative 22 (37.3) 80 (17.7) <0.001
Positive 37 (62.7) 371 (82.3)
Missing 2 23
p21 expression
Negative 20 (33.9) 53 (11.8) <0.001
Positive 39 (66.1) 396 (88.2)
missing 2 25

The categories marked as missing were not included in the analysis.

Bengtsson et al.

Bengtsson et al. Diagnostic Pathology 2014 9:78   doi:10.1186/1746-1596-9-78

Open Data